Antithrombotic therapy following lower extremity endovascular revascularization: The results of a survey of vascular specialists.

ABSTRACT:

Objective

Antithrombotic therapy improves endovascular intervention outcomes for peripheral artery disease. However, there are limited data guiding the choice and duration of these adjuvant therapies. Thus, we explored current antithrombotic prescribing preferences among vascular interventionalists, hypothesizing that there are varied and inconsistent treatment practices among providers.

Methods

We developed and distributed a de-identified RedCap survey via Twitter and email to Vascular Quality Initiative members (February 2023). Multiple-choice questions queried antithrombotic agents and treatment durations for a clinical vignette (a claudicant on 81 mg aspirin and statin) with different arterial disease locations (iliac, femoropopliteal, or tibial vessels) and different re

SUBMITTER: Jarosinski MC 

PROVIDER: S-EPMC11774505 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature